However, obesity and hyperinsulinemia, which are frequently observed in adolescents with PCOS, exacerbate diagnostic challenges by altering key biomarkers such as the FAI and SHBG, making it difficult to distinguish PCOS from other anovulatory conditions. This evidence concerns the gene SHBG and polycystic ovary syndrome.